Skip to the page

Data / Form D filings / J2 Health, Inc.

J2 Health, Inc.: Form D filing

J2 Health, Inc., a company in New York, NY, filed a Form D with the SEC in 2025. The latest, on April 28, 2025, reports $1 million sold of a $1 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
244 5TH AVENUE, SUITE A241, New York, NY, 10001
Phone
(917) 597-9841
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2064452

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 28, 2025New notice$1,008,690$1,008,6905Mar 12, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joshua PoretzExecutive Officer, Director

Other companies in New York that filed recently

Every Form D from the week of Apr 28, 2025 · All recent filings in New York · All recent Other filings

Read from SEC EDGAR. Amount sold is what J2 Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.